AK Medical Holdings Ltd. (HK:1789)
:1789
Top Page
AK Medical Holdings Ltd.
(1789)
Select Model
Select Model
Rating:74Outperform
Price Target:
HK$6.50
▲(9.98% Upside)
Action:ReiteratedDate:11/01/25
AK Medical Holdings Ltd. earns an overall stock score of 74, driven primarily by its strong financial performance (score: 83, weight: 50%), reflecting robust profitability, low leverage, and solid equity structure. Technical analysis (score: 60, weight: 30%) and valuation (score: 65, weight: 20%) are more neutral, with fair pricing and mixed momentum signals. Financial health is the key strength, though cash flow volatility remains a minor concern.
Positive Factors
Revenue Growth
The company's robust revenue growth indicates a strong market position and effective product adoption, supporting long-term business expansion.
Negative Factors
Cash Flow Management
Inconsistent cash flow management can hinder the company's ability to fund operations and growth initiatives, posing a risk to financial stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The company's robust revenue growth indicates a strong market position and effective product adoption, supporting long-term business expansion.
Read all positive factors
AK Medical Holdings Ltd. (1789) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$7.21B
Dividend Yield1.26%
Average Volume (3M)4.30M
Price to Earnings (P/E)17.3
Beta (1Y)1.10
Revenue Growth25.18%
EPS Growth55.79%
CountryHK
Employees950
SectorHealthcare
Sector Strength45
IndustryMedical - Devices
Share Statistics
EPS (TTM)0.18
Shares Outstanding1,123,920,300
10 Day Avg. Volume3,969,892
30 Day Avg. Volume4,297,109
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)1.93
Price to Sales (P/S)3.78
P/FCF Ratio17.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.01Price Target Upside35.45% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)0.37
Revenue Forecast (FY)HK$1.68B
AK Medical Holdings Ltd. Business Overview & Revenue Model
Company Description
AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spine replacement...
How the Company Makes Money
AK Medical Holdings generates revenue through the sale of its orthopedic products, including joint implants and surgical instruments, to hospitals and clinics. The company has multiple revenue streams, primarily from the direct sales of its produc...
AK Medical Holdings Ltd. Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
90
Very Positive
Cash Flow
75
Positive
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.38B | 1.35B | 1.09B | 1.05B | 761.44M | 1.04B |
| Gross Profit | 820.05M | 808.19M | 674.49M | 636.43M | 499.19M | 714.53M |
| EBITDA | 383.27M | 371.66M | 323.34M | 322.87M | 184.33M | 438.41M |
| Net Income | 295.28M | 273.93M | 182.10M | 204.77M | 92.62M | 314.01M |
Balance Sheet | ||||||
| Total Assets | 3.56B | 3.34B | 3.00B | 2.77B | 2.61B | 2.53B |
| Cash, Cash Equivalents and Short-Term Investments | 1.52B | 1.05B | 726.67M | 1.04B | 841.13M | 901.49M |
| Total Debt | 153.99M | 99.39M | 84.20M | 38.78M | 41.56M | 26.85M |
| Total Liabilities | 828.14M | 697.21M | 611.12M | 530.73M | 573.73M | 484.13M |
| Stockholders Equity | 2.73B | 2.64B | 2.39B | 2.24B | 2.03B | 2.04B |
Cash Flow | ||||||
| Free Cash Flow | 281.75M | 289.11M | -162.14M | 121.20M | 100.39M | 115.47M |
| Operating Cash Flow | 354.22M | 451.07M | 33.94M | 242.92M | 176.62M | 205.26M |
| Investing Cash Flow | -526.02M | -393.35M | -318.15M | -82.29M | -297.10M | -356.41M |
| Financing Cash Flow | -40.87M | -39.43M | -14.02M | -36.80M | -100.70M | 611.74M |
AK Medical Holdings Ltd. Technical Analysis
Positive
5.91
Price Trends
5.99
Positive
5.88
Positive
5.94
Positive
Market Momentum
0.08
Negative
62.55
Neutral
89.52
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1789, the sentiment is Positive. The current price of 5.91 is below the 20-day moving average (MA) of 5.97, below the 50-day MA of 5.99, and below the 200-day MA of 5.94, indicating a bullish trend. The MACD of 0.08 indicates Negative momentum. The RSI at 62.55 is Neutral, neither overbought nor oversold. The STOCH value of 89.52 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1789.
AK Medical Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$7.21B | 17.31 | 11.91% | 1.26% | 25.18% | 55.79% | |
69 Neutral | HK$7.66B | 19.30 | 9.39% | 1.88% | 14.56% | 61.60% | |
58 Neutral | HK$8.16B | 27.86 | 4.88% | 0.48% | 35.01% | 483.73% | |
57 Neutral | HK$7.86B | 36.52 | 1.98% | ― | 3.42% | -70.82% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$4.12B | -6.84 | -11.27% | ― | 29.25% | 9.02% |
* Healthcare Sector Average
HK:1789
AK Medical Holdings Ltd.
6.43
0.65
11.25%
HK:9996
Peijia Medical Ltd.
6.14
1.72
38.91%
HK:2190
Zylox-Tonbridge Medical Technology Co., Ltd. Class H
23.70
8.85
59.55%
HK:1302
LifeTech Scientific Corporation
1.82
0.48
35.82%
HK:1858
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
13.07
4.24
48.02%
AK Medical Holdings Ltd. Corporate Events
AK Medical Holdings Ltd. Strengthens Governance with New Nomination Committee
Dec 4, 2025
AK Medical Holdings Ltd. has established a nomination committee as part of its corporate governance structure. The committee, primarily composed of independent non-executive directors, is tasked with reviewing the board’s structure, diversit...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.